SCHEMBL17490272

SCHEMBL17490272

Cc1c(C)c(C)c2c(c1C)C(=O)C=CC2=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 3/20 0.41
AURKA O14965 2/20 0.41
AURKB Q96GD4 2/20 0.41
CYP1A1 P04798 1/20 0.41
CYP1A2 P05177 1/20 0.41
TXNRD1 Q16881 1/20 0.41
TXNRD3 Q86VQ6 1/20 0.41
COPS5 Q92905 1/20 0.41
TXNRD2 Q9NNW7 1/20 0.41
PIM1 P11309 3/20 0.39
MAPT P10636 4/20 0.39
MAPK1 P28482 4/20 0.39
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 2/20 0.39
USP2 O75604 2/20 0.39
TP53 P04637 2/20 0.39
CYP3A4 P08684 2/20 0.39
THRB P10828 2/20 0.39
HPGD P15428 2/20 0.39
ALOX15 P16050 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14253089 0.73 CDC25B (0.48) CDC25BAURKAAURKBCYP1A1CYP1A2
SCHEMBL30029972 0.73 CDC25B (0.48) CDC25BAURKAAURKBCYP1A1CYP1A2
SCHEMBL5606117 0.73 CCR6 (0.47) MAPTMAPK1ALDH1A1MEN1HPGD
SCHEMBL19104637 0.72 PIM1 (0.35) CDC25BAURKAAURKBCYP1A1CYP1A2
Naphthoquinone SCHEMBL11308377 0.70 CDC25B (0.61) CDC25BAURKAAURKBCYP1A2MAPT
SCHEMBL15698060 0.69 ALDH1A1 (0.54) CDC25BCYP1A1CYP1A2TXNRD1MAPT
SCHEMBL13943557 0.69 KDM4E (0.39) CDC25BCYP1A1CYP1A2TXNRD1PIM1
SCHEMBL48972 0.67 CDC25B (0.47) CDC25BAURKAAURKBCYP1A1CYP1A2
SCHEMBL57098 0.67 TDP2 (0.35) MAPTMEN1USP2THRBKMT2A
SCHEMBL17581080 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12576382-B2 Ceramic coating on metal parts to reduce deposit of metallic transition metals in hydrogenation reactions DSM IP ASSETS B.V. (NL) 2026-03-17 US disclosed
US-20230338915-A1 CERAMIC COATING ON METAL PARTS TO REDUCE DEPOSIT OF METALLIC TRANSITION METALS IN HYDROGENATION REACTIONS DSM IP ASSETS B.V. (NL) 2023-10-26 US disclosed
CN-116194204-A Ceramic coating for reducing deposition of metallic transition metals on metal parts in hydrogenation reactions 帝斯曼知识产权资产管理有限公司 2023-05-30 CN disclosed
WO-2022058576-A1 CERAMIC COATING ON METAL PARTS TO REDUCE DEPOSIT OF METALLIC TRANSITION METALS IN HYDROGENATION REACTIONS DSM IP ASSETS B.V. (NL) 2022-03-24 WO disclosed
US-9620297-B2 Electricity storage device and electrode material therefor TOHOKU UNIVERSITY (JP) 2017-04-11 US disclosed
US-20160035498-A1 ELECTRICITY STORAGE DEVICE AND ELECTRODE MATERIAL THEREFOR TOHOKU UNIVERSITY (JP) 2016-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12576382-B2 Ceramic coating on metal parts to reduce deposit of metallic transition metals in hydrogenation reactions CAD, EZH2, ZW10 CDC25B 3392/4885AURKA 789/4885AURKB 2604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.